loadpatents
Patent applications and USPTO patent grants for Lesburg; Charles A..The latest application filed is for "arginase inhibitors and methods of use".
Patent | Date |
---|---|
Oxo-tetrahydro-isoquinoline carboxylic acids as STING inhibitors Grant 11,311,528 - Altman , et al. April 26, 2 | 2022-04-26 |
Arginase inhibitors and methods of use Grant 11,274,111 - Achab , et al. March 15, 2 | 2022-03-15 |
Arginase Inhibitors And Methods Of Use App 20220056051 - Achab; Abdelghani Abe ;   et al. | 2022-02-24 |
Arginase Inhibitors And Methods Of Use App 20210163505 - Achab; Abdelghani Abe ;   et al. | 2021-06-03 |
Automatic protein crystallization trial analysis system Grant 11,010,591 - Ghafurian , et al. May 18, 2 | 2021-05-18 |
Oxo-tetrahydro-isoquinoline Carboxylic Acids As Sting Inhibitors App 20210052573 - Altman; Michael D. ;   et al. | 2021-02-25 |
Arginase Inhibitors And Methods Of Use App 20210040127 - Achab; Abdelghani Abe ;   et al. | 2021-02-11 |
Automatic Protein Crystallization Trial Analysis System App 20200250397 - Kind Code | 2020-08-06 |
Inhibitors of IRAK4 activity Grant 9,969,749 - Altman , et al. May 15, 2 | 2018-05-15 |
Inhibitors of IRAK4 activity Grant 9,943,516 - Altman , et al. April 17, 2 | 2018-04-17 |
Inhibitors of IRAK4 activity Grant 9,932,350 - Altman , et al. April 3, 2 | 2018-04-03 |
Inhibitors of IRAK4 activity Grant 9,926,330 - Altman , et al. March 27, 2 | 2018-03-27 |
Inhibitors Of Irak4 Activity App 20170275297 - ALTMAN; MICHAEL D. ;   et al. | 2017-09-28 |
Inhibitors Of Irak4 Activity App 20170247388 - ALTMAN; MICHAEL D. ;   et al. | 2017-08-31 |
Inhibitors Of Irak4 Activity App 20170217981 - ALTMAN; MICHAEL D. ;   et al. | 2017-08-03 |
Inhibitors Of Irak4 Activity App 20170209446 - ALTMAN; MICHAEL D. ;   et al. | 2017-07-27 |
Factor XIa inhibitors Grant 9,663,527 - Neelamkavil , et al. May 30, 2 | 2017-05-30 |
FACTOR XIa INHIBITORS App 20160347757 - Neelamkavil; Santhosh F. ;   et al. | 2016-12-01 |
3-heterocyclic substituted indole derivatives and methods of use thereof Grant 8,765,757 - Chan , et al. July 1, 2 | 2014-07-01 |
Substituted indole derivatives and methods of use thereof Grant 8,614,229 - Anilkumar , et al. December 24, 2 | 2013-12-24 |
4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections Grant 8,557,848 - Chen , et al. October 15, 2 | 2013-10-15 |
2,3-substituted indole derivatives for treating viral infections Grant 8,143,305 - Anilkumar , et al. March 27, 2 | 2012-03-27 |
Crystal of pregnane X receptor fused to steroid receptor coactivator-1 Grant 8,048,663 - Wang , et al. November 1, 2 | 2011-11-01 |
3-heterocyclic Substituted Indole Derivatives And Methods Of Use Thereof App 20110165118 - Chan; Tin-Yau ;   et al. | 2011-07-07 |
Substituted Indole Derivatives And Methods Of Use Thereof App 20110104110 - Anikumar; Gopinadhan N. ;   et al. | 2011-05-05 |
2,3-substituted Indole Derivatives For Treating Viral Infections App 20110033417 - Anilkumar; Gopinadhan N. ;   et al. | 2011-02-10 |
Pregnane X Receptor Compositions, Crystals and Uses Thereof App 20100286372 - Wang; Wenyan ;   et al. | 2010-11-11 |
Pregnane X receptor compositions, crystals and uses thereof Grant 7,785,879 - Wang , et al. August 31, 2 | 2010-08-31 |
4,5-ring Annulated Indole Derivatives For Treating Or Preventing Of Hcv And Related Viral Infections App 20100098661 - Chen; Kevin X. ;   et al. | 2010-04-22 |
Pyrrolo [3, 2-a] Pyridine Derivatives For Inhibiting Ksp Kinesin Activity App 20100068181 - Paliwal; Sunil ;   et al. | 2010-03-18 |
Compounds for inhibiting KSP kinesin activity App 20060247320 - Tagat; Jayaram R. ;   et al. | 2006-11-02 |
Compositions of hepatitis C virus NS5B polymerase and methods for crystallizing same App 20030171874 - Lesburg, Charles A. ;   et al. | 2003-09-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.